SightfileU.S. market data from official filings

SANARA MEDTECH INC (SMTI)

Name: SANARA MEDTECH INC (SMTI) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000714256 · EDGAR filings · Updated 2026-06-09

SANARA MEDTECH INC (SMTI) has reported institutional ownership of 16.3%, with 65 institutional managers holding positions valued at $25.6M per the latest 13F reporting period.

Institutional ownership

16.3%

Institutional managers

Reported 13F value

$25.6M

Insider activity

26 trans.

$0 net flat

Latest updates

2026-06-09 — Current report (8-K) filed
2026-06-05 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SANARA MEDTECH INC has 65 institutional holders and institutional ownership of 16.3%.

Insider activity

Insiders reported 26 transactions (0 buys, 0 sells) across 13 reporting insiders, with a net reported value of $0.

Related companies

IMAGENEBIO INC (IMA) · STREAMEX (STEX) · SANGAMO THERAPEUTICS INC (SGMOQ) · VERRICA PHARMACEUTICALS INC (VRCA) · LIPOCINE INC NEW (LPCN) · TELIX PHARMACEUTICAL LTD (TLX)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-09.